Boston Scientific's SWOT analysis: medtech giant's stock poised for growth
Boston Scientific Corporation (NYSE:BSX), a leading player in the medical technology sector, has been making significant ...
Boston Scientific's (NYSE:BSX) five-year earnings growth trails the solid shareholder returns
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you ...
bovnews2d
The Boston Scientific Corp Stock Thriller: Decoding the Mystery Behind BSX’s Recent Movements
Boston Scientific Corp (BSX) stock saw a decline, ending the day at $100.31 which represents a decrease of $-0.60 or -0.59% from the prior close of $100.91. The stock opened at $100.91 and touched a ...
bovnews4d
Analysts Predict a $108 Target for Boston Scientific Corp (BSX) Stock—What Could Drive It There?
Boston Scientific Corp (BSX) stock saw a modest uptick, ending the day at $98.66 which represents a slight increase of $0.49 or 0.50% from the prior close of $98.17. The stock opened at $97.93 and ...
Boston Scientific Corp. stock underperforms Thursday when compared to competitors despite daily gains
Boston Scientific Corp. closed 0.01% short of its 52-week high of $101.65, which the company reached on January 22nd.
MassDevice9d
Boston Scientific data supports Farapulse, Watchman FLX
Boston Scientific (NYSE: BSX) today reported data from separate studies backing its Farapulse and Watchman FLX systems.
Boston Scientific price target raised to $111 from $86 at Barclays
Barclays raised the firm’s price target on Boston Scientific (BSX) to $111 from $86 and keeps an Overweight rating on the shares. The firm says ...